SRRK(Scholar Rock Holding Corporation) · 财务报表

SRRK(Scholar Rock Holding Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2019-12-31FY 截至 2020-12-31FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2025-12-31
营业收入$20.49M$15.40M$18.82M$33.19M$0
毛利润—————
营业利润−$54.54M−$86.88M−$129.92M−$134.37M−$384.64M
净利润−$51.00M−$86.48M−$131.80M−$134.50M−$377.94M
经营现金流−$63.12M−$60.27M−$126.79M−$132.69M−$300.04M
自由现金流−$66.23M−$64.36M−$132.04M−$133.76M−$300.64M
摊薄每股收益$-1.85$-2.81$-3.59$-2.26$-3.29

Scholar Rock Holding Corporation SRRK